4//SEC Filing
Warmuth Markus 4
Accession 0000899243-22-008673
CIK 0001826457other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:26 PM ET
Size
5.4 KB
Accession
0000899243-22-008673
Insider Transaction Report
Form 4
Warmuth Markus
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+315,600→ 315,600 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (315,600 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001855643
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:26 PM ET
- Size
- 5.4 KB